Nexium Approved for Children Ages 1-11 Years Old

U.S. Food and Drug Administration (FDA) has approved the use of Nexium (esomeprazole), one of a group of drugs called Proton Pump Inhibitors (PPIs), in children ages 1 to 11 years old for the short-term treatment of gastroesophageal reflux disease (GERD). The FDA said these pediatric patients shouldn't take Nexium for more than 8 weeks,

Nexium had already been approved in April 2006 for adolescents 12 to 17 years old for the treatment of GERD.

GERD isn't just a condition that affects adults. Researchers acknowledge that GERD has become increasingly common in children, and, if left untreated, can lead to potentially serious complications such as erosive esophagitis.

The FDA has approved a new 10 mg dose formulation of Nexium for Delayed-Release Oral Suspension for use in children 1 to 11 years old. This 10 mg dose formulation is in addition to the 20 and 40 mg Nexium for Delayed- Release Oral Suspension, which were approved in October 2006 for use in adolescent patients 12 to 17 years old, as well as adults.

Related Resources:

• Infants with GERD
• Children with GERD
• Teens with GERD
• Proton Pump Inhibitors
• Nexium
• Erosive esophagitis